PURPOSE: Recurrent disease following complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a relevant clinical scenario. We aimed to determine risk factors for recurrence. METHODS: Prospectively collected data of patients enrolled in the Peritoneal Surface Malignancy Program at the University of Tübingen between 2005 and 2011 were retrospectively analyzed. All patients were treated by standardized CRS and HIPEC. Recurrence was defined either radiographically by CT, PET-CT scan, or reoperation. RESULTS: Fifty-two patients received complete CRS (CC-0/CC-1) and HIPEC. Median time to recurrence was 229 days (103-1,028). Overall recurrence rate within follow-up was 48 %. Of patients with recurrent disease, 44 % experienced extraperitoneal systemic tumor spread. In multivariate analysis, grading of ≥ 3 was shown as an independent risk factor for recurrent disease, while a trend was observed for maximal tumor load in the upper abdominal region. Clinical parameters did not show an impact on recurrence. CONCLUSIONS: Primary tumor grading seems to be an independent risk factor for recurrence following complete CRS and HIPEC in colorectal cancer-derived peritoneal surface malignancies.
PURPOSE: Recurrent disease following complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a relevant clinical scenario. We aimed to determine risk factors for recurrence. METHODS: Prospectively collected data of patients enrolled in the Peritoneal Surface Malignancy Program at the University of Tübingen between 2005 and 2011 were retrospectively analyzed. All patients were treated by standardized CRS and HIPEC. Recurrence was defined either radiographically by CT, PET-CT scan, or reoperation. RESULTS: Fifty-two patients received complete CRS (CC-0/CC-1) and HIPEC. Median time to recurrence was 229 days (103-1,028). Overall recurrence rate within follow-up was 48 %. Of patients with recurrent disease, 44 % experienced extraperitoneal systemic tumor spread. In multivariate analysis, grading of ≥ 3 was shown as an independent risk factor for recurrent disease, while a trend was observed for maximal tumor load in the upper abdominal region. Clinical parameters did not show an impact on recurrence. CONCLUSIONS:Primary tumor grading seems to be an independent risk factor for recurrence following complete CRS and HIPEC in colorectal cancer-derived peritoneal surface malignancies.
Authors: J C Cusack; G G Giacco; K Cleary; B S Davidson; F Izzo; J Skibber; J Yen; S A Curley Journal: J Am Coll Surg Date: 1996-08 Impact factor: 6.113
Authors: Klaus Günther; Otto Dworak; Stefan Remke; Rafael Pflüger; Susanne Merkel; Werner Hohenberger; Marc A Reymond Journal: J Surg Res Date: 2002-03 Impact factor: 2.192
Authors: Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder Journal: J Clin Oncol Date: 2003-10-15 Impact factor: 44.544
Authors: Vic J Verwaal; Henk Boot; Berthe M P Aleman; Harm van Tinteren; Frans A N Zoetmulder Journal: Ann Surg Oncol Date: 2004-03-15 Impact factor: 5.344
Authors: Terence C Chua; Tristan D Yan; Michelle E Smigielski; Katherine J Zhu; Keh M Ng; Jing Zhao; David L Morris Journal: Ann Surg Oncol Date: 2009-04-23 Impact factor: 5.344
Authors: Philipp Horvath; Stefan Beckert; Florian Struller; Alfred Königsrainer; Ingmar Königsrainer Journal: World J Gastrointest Pharmacol Ther Date: 2016-08-06
Authors: Emma C Hulshof; Lifani Lim; Ignace H J T de Hingh; Hans Gelderblom; Henk-Jan Guchelaar; Maarten J Deenen Journal: Front Pharmacol Date: 2020-10-06 Impact factor: 5.810
Authors: Emily Wonder; Lorena Simón-Gracia; Pablo Scodeller; Ramsey N Majzoub; Venkata Ramana Kotamraju; Kai K Ewert; Tambet Teesalu; Cyrus R Safinya Journal: Biomaterials Date: 2018-03-02 Impact factor: 12.479
Authors: Talat A M Albukhari; Hanaa Nafady-Hego; Hamed Elgendy; Hanan M Abd Elmoneim; Asmaa Nafady; Abdulaziz M Alzahrani Journal: Int J Microbiol Date: 2019-08-01